Exagen Inc (XGN)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $96.19M
Last updated: Nov 17, 2026 at 4:13 PM ET
Exagen Inc (XGN) Stock Chart
Exagen (XGN) has a latest price of $3.76 on Nov 17, 2026, 59.2% below its 52-week high of $9.22. Its price fell 58.3% over the past 12 months. The month-end price fell 26.1% over the 5 years through Oct 2026, a compound annual decline of 5.9%.
Price Chart
From Sep 2019 to Oct 2026, its highest month-end close was $25.40 in Dec 2019 and its lowest $1.39 in Apr 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart XGN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for XGN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 49.4%, and over 6 months it rose 0.8%. The month-end price rose 402.3% over the 3 years through Oct 2026, a compound annual rate of 71.3%.
| Period | Change |
|---|---|
| 1 month | -49.4% |
| 3 months | -49.4% |
| 6 months | +0.8% |
| 12 months | -58.3% |
| 12 months, with dividends | -58.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +402.3% | +71.3% |
| 5 years | -26.1% | -5.9% |
Price by Year
Its best calendar year was 2024, when the price rose 106.0%, and its weakest was 2022, when it fell 79.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $8.59 | +41.3% |
| 2025 | $6.08 | +48.3% |
| 2024 | $4.10 | +106.0% |
| 2023 | $1.99 | -17.1% |
| 2022 | $2.40 | -79.4% |
| 2021 | $11.63 | -11.9% |
| 2020 | $13.20 | -48.0% |
Trading Range
The price is 50.3% below its 50-day average of $7.56 and 26.6% below its 200-day average of $5.12.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.76 | |
| 52-week high | $9.22 | -59.2% |
| 52-week low | $2.59 | +45.2% |
| 50-day average | $7.56 | -50.3% |
| 200-day average | $5.12 | -26.6% |
Price Risk
Over 3 years, its largest fall from a peak was 77.8%.
| Measure | Value |
|---|---|
| 1-year beta | 2.67 |
| Largest fall, 1 year | -68.7% |
| Largest fall, 3 years | -77.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About XGN
What is XGN's 1-year price change?
Exagen's price fell 58.3% over the past 12 months. With dividends included, the 12-month total return was -58.3%.
What is XGN's 5-year price change?
Exagen's month-end price fell 26.1% over the 5 years through Oct 2026, a compound annual decline of 5.9%. These figures leave out dividends.
What is XGN's 52-week high and low?
Exagen's 52-week high is $9.22 and its 52-week low is $2.59. Its latest price of $3.76 on Nov 17, 2026 is 59.2% below the high.
What is XGN's beta?
Exagen's 1-year beta against the S&P 500 is 2.67, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 68.7%.
Is the XGN chart free?
Yes. Advanced Charting for XGN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
XGN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors